Angitia Biopharmaceuticals Announces $120 Million Series C Financing [Yahoo! Finance]
Janus Henderson Group plc Ordinary Shares (JHG)
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am
Check Earnings Report
US:NYSE Investor Relations:
snl.com/irw/corporateprofile/4147331
Company Research
Source: Yahoo! Finance
- Proceeds will support the development of AGA2118, AGA2115, AGA111 and other pipeline assets for the treatment of serious musculoskeletal diseases - Norbert Riedel, Ph.D., will join the Board of Directors WOODLAND HILLS, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals (“Angitia” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced the closing of a $120 million Series C financing round. Bain Capital Life Sciences led the financing, with participation from new investor Janus Henderson and existing investors OrbiMed, 3H Health Investment, Yonghua Capital, Legend Capital, and Elikon Venture. Proceeds from the Series C will support Angitia's robust pipeline of novel, differentiated treatments for serious musculoskeletal diseases. “The broad support for Angitia in this financing validates the hard work of our team, the clinical progress
Show less
Read more
Impact Snapshot
Event Time:
JHG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JHG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JHG alerts
High impacting Janus Henderson Group plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JHG
News
- Janus Henderson Group plc (NYSE: JHG) had its price target raised by analysts at Morgan Stanley from $46.00 to $48.00. They now have an "equal weight" rating on the stock.MarketBeat
- Sony's Record Climb Makes Investors More Bullish on Gaming Boom [Yahoo! Finance]Yahoo! Finance
- Directorate change [Yahoo! Finance]Yahoo! Finance
- Ottimo Pharma Raises over $140 Million in Series A Financing [Yahoo! Finance]Yahoo! Finance
- Morning Bid: Fed's 'hawkish cut' slams markets, BOJ up next [Yahoo! Finance]Yahoo! Finance
JHG
Earnings
- 10/31/24 - Beat
JHG
Sec Filings
- 11/14/24 - Form 13F-HR
- 11/14/24 - Form SC
- 11/8/24 - Form 3
- JHG's page on the SEC website